PPARG and in situ carcinoma: Figure 8A–C showed that CIS decreased SIRT1 and PPARγ levels significantly in the lung of rats (p < 0.001). Similarly, the data in Figure 9A,B showed a significant downregulation of Cygb in the lungs of CIS-treated rats.